Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes

Gerontology

Volumn 49, Issue 2, 2003, Pages 86-92

  Hewer, Walter ^a,d   Mussell, M ^a   Rist, F ^b   Kulzer, B ^c   Bergis, K ^c  

^a Central Institute of Mental Health   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Diabetes Zentrum Mergentheim   (Germany)

^d Vinzenz von Paul Hospital   (Germany)

Author keywords

Cognitive function; Glucose; Insulin; Memory; Metabolic control; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGE; AGED; ARTICLE; ATTENTION; BRAIN DYSFUNCTION; CLINICAL TRIAL; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; EDUCATION; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; METABOLISM; MOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REGULATORY MECHANISM; SCORING SYSTEM; STANDARDIZATION; TIME; TREATMENT FAILURE; VERBAL MEMORY;

ADULT; AGED; AGING; ANALYSIS OF VARIANCE; ATTENTION; BLOOD GLUCOSE; CLUSTER ANALYSIS; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE;

EID: 0037266118     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067947     Document Type: Article

References (37)

1. Ryan CM, Geckle M: Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000; 16:308-315.
2. Strachan MW, Deary IJ, Ewing FME, Frier BM: Is type II diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care 1997;20:438-445.
3. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H: The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993;48: M117-M121.
4. Gradman TJ, Laws A, Thompson LW, Reaven GM: Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993;41:1305-1312.
5. Naor M, Steingrüber HJ, Westhoff K, Schottenfeld-Naor Y, Gries FA: Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. J Diabetes Complications 1997;11:40-46.
6. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183-1197.
7. Lehrl S: Mehrfachwahl-Wortschatz-Intelligenztest: MWT-B, ed 2. Nürnberg, Medizini-sche Verlagsgesellschaft, 1989.
8. Wilson DH, Bogacz JP, Forsythe CM, Turk PJ, Lane TL, Gates RC, Brandt DR: Fully automated assay of glycohemoglobin with the Abbott IMx® analyzer: Novel approaches for separation and detection. Clin Chem 1993;39: 2090-2097.
9. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonkens PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital population. Diabetologia 1993;36:150-154.
10. Mogensen CE, Christiansen K, Vittinghus E: The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32(suppl 2):64-78.
11. The American Academy of Ophthalmology: Preferred practice pattern: Diabetic retinopathy. San Francisco, The American Academy of Ophthalmology, 1989.
12. World Health Organization: WHO-Report Hypertension Control. Tech Rep Ser No. 862. Geneva, WHO, 1996.
13. Bergis KH: Korrektur der Insulinresistenz mit Insulin. Schriftenr Diabetes Akad Bad Mergentheim 1989;34:98-103.
14. Oswald WD, Roth E: Der Zahlen-Verbindungs-Test (ZVT), ed 2. Göttingen, Hogrefe, 1987.
15. Lezak MD: Neuropsychological Assessment, ed 3. Oxford, New York University Press, 1995.
16. Eriksen CW, Eriksen BA: Effects of noise letters upon the identification of a target letter in a non-search task. Percept Psychophys 1974;16:143-149.
17. Borkowski JG, Benton AL, Spreen O: Word fluency and brain damage. Neuropsychologia 1967;5:135-140.
18. Rey A: L'examen clinique en psychologique. Paris, Presses Universitaires de France, 1964.
19. Geffen G, Moar KJ, O'Hanlon AP, Clark CR, Geffen LB: Performance measures of 16- to 86-year-old males and females on the auditory verbal learning test. Clin Neuropsychol 1990;4: 45-63.
20. Heubrock D: Der Auditiv-Verbale-Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse. Z Differ Diagn Psychol 1992;13:161-174.
21. Von Zerssen D: Klinische Selbstbeurteilungs-Skalen (Ksb-S) aus dem Münchner Psychiatrischen Informations-System (PSYCHIS München). Depressivitäts-Skala (D-S). Weinheim, Beltz, 1976.
22. Von Zerssen D: Klinische Selbstbeurteilungs-Skalen (Ksb-S) aus dem Münchner Psychiatrischen Informations-System (PSYCHIS München). Die Befindlichkeits-Skala (Bf-S). Weinheim, Beltz, 1976.
23. Strachan MWJ, Frier BM, Deary IJ: Cognitive assessment in diabetes: The need for consensus. Diabet Med 1997;14:421-422.
24. Stewart R, Liolitsa D: Type 2 diabetes, cognitive impairment and dementia. Diabet Med 1999;16:93-112.
25. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
26. Elias PK, Elias MF, D'Agostino RB, et al: NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997;20:1388-1395.
27. Stolk RP, Breteler MMB, Ott A, et al: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 1997;20:792-795.
28. Allen JB, Gross AM, Aloia MS, Billingsley C: The effects of glucose on nonmemory cognitive functioning in the elderly. Neuropsychologia 1996;34:459-465.
29. Manning CA, Stone WS, Korol DL, Gold PE: Glucose enhancement of 24-hour memory retrieval in healthy elderly humans. Behav Brain Res 1998;93:71-76.
30. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). lancet 1998;352:847-853.
31. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. A randomized, controlled, double-blind trial. JAMA 1998;280:1490-1496.
32. Draelos MT, Jacobson AM, Weinger K, Widom B, Ryan CM, Finkelstein DM, Simonson DC: Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med 1995;98:135-144.
33. Mooradian AD: Pathophysiology of central nervous complications in diabetes mellitus. Clin Neurosci 1997;4:322-326.
34. Rost K, Roter D, Quill T, Bertakis K: Capacity to remember prescription drug changes: Deficits associated with diabetes. Collaborative Study Group of the Task Force on the Medical Interview. Diabetes Res Clin Pract 1990;10:183-187.
35. Sinclair AJ, Girling AJ, Bayer AJ: Cognitive dysfunction in older subjects with diabetes mellitus: Impact on diabetes self-management and use of care services. Diabetes Res Clin Pract 2000;50:203-212.
36. Rockwood K, Stolee P, McDowell I: Factors associated with institutionalization of older people in Canada: Testing a multifactorial definition of frailty. J Am Geriatr Soc 1996;44:578-582.
37. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937-1942.